Venetoclax and obinutuzumab funded in England by NICE, acalabrutinib licensed- the end of FCR chemotherapy for CLL?
Today NICE announced that they have agreed to fund Venetocolax plus obinutuzamab for all first line patients with CLL who want to take it in England. …